Antimicrobial resistance: A global multifaceted phenomenon

Pathogens and Global Health

Volumn 109, Issue 7, 2015, Pages 309-318

  Prestinaci, Francesca ^a   Pezzotti, Patrizio ^a   Pantosti, Annalisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antibiotic use; Antimicrobial resistance; Global surveillance; Klebsiella pneumoniae; MRSA; Mycobaterium tuberculosis; Non typhoidal salmonella; Veterinary medicine

Indexed keywords

PENICILLIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CYSTITIS; DRUG RESISTANT TUBERCULOSIS; ERWINIA AMYLOVORA; FLU LIKE SYNDROME; HEALTH IMPACT ASSESSMENT; HEALTH PRACTITIONER; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN INTENSIVE CARE; PNEUMONIA; REVIEW; SALMONELLA; SOFT TISSUE INFECTION; WASTE WATER MANAGEMENT; ANIMAL; DRUG EFFECTS; DRUG UTILIZATION; HEALTH; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, MULTIDRUG-RESISTANT; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; GLOBAL HEALTH; HUMANS; KLEBSIELLA PNEUMONIAE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; TUBERCULOSIS, MULTIDRUG-RESISTANT; VETERINARY MEDICINE;

EID: 84958540384     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773215Y.0000000030     Document Type: Review

References (64)

1. World Health Organization. WHO global strategy for containment of antimicrobial resistance. Geneva: WHO; 2001.
2. World Health Organization. The evolving threat of antimicrobial resistance. Options for action. Geneva: WHO Library Cataloguing-in-Publication Data; 2012.
3. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Geneva, Switzerland: WHO; 2014.
4. Centres for Disease Control and Prevention, U S Department of Health and Human Services. Antibiotic resistance threats in the United States. Atlanta: CDC; 2013. Available from: http://www. cdc. gov/drugresistance/pdf/ar-threats-2013-508. pdf.
5. ECDC/EMEA. The bacterial challenge: time to react. Stockholm: European Center for Disease Prevention and Control; 2009.
6. Nesher L, Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 2014; 42(1): 5-13.
7. Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, Mlynarczyk G, et al. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc. 2014; 46(8): 2777-81.
8. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010; 126(3): 443-56.
9. Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol. 2010; 37(3): 547-63.
10. Vincent J. Nosocomial infections in adult intensive-care units. Lancet. 2003; 361(9374): 2068-77.
11. European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe 2012. Stockholm: ECDC; 2014. Available from: http://ecdc. europa. eu/en/publications/Publications/antimicrobial-consumption-europe-esac-net-2012. pdf.
12. Suetens C, Hopkins S, Kolman J, Diaz Hogberg L. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2013.
13. Hicks LA, Taylor TH Jr, Hunkler RJ. US outpatient antibiotic prescribing, 2010. N Engl J Med. 2013; 368(15): 1461-2.
14. Polk RE. Variability in rates of Use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol. 2008; 29(3): 203-11.
15. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther. 2012; 10(4): 445-57.
16. Special Eurobarometer 338. Antimicrobial resistance, Novem-ber-December 2009. Brussels: TNS Opinion & Social; 2010.
17. McNulty CA, Boyle P, Nichols T, Clappison P, Davey P. Don't wear me out-the public's knowledge of and attitudes to antibiotic use. J Antimicrob Chemother. 2007; 59(4): 727-38.
18. Andre M, Vernby A, Berg J, Lundborg CS. A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden. J Antimicrob Chemother. 2010; 65(6): 1292-6.
19. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011; 11(9): 692-701.
20. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011; 24(4): 718-33.
21. Safety Ef, editor. Regulation European. Ban on antibiotics as growth promoters in animal feed enters into effect (1831/2003/EC). Brussels: Europa; 2005.
22. European Medicines Agency (EMA). Sales of veterinary antimicrobial agents in 26 EU/EEA countries in 2012 Fourth ESVAC report. 2014. (EMA/333921/2014). Available from: http://www. ema. europa. eu/docs/en_GB/document_library/Report/2014/10/WC500175671. pdf.
23. Food and Drug Administration (FDA) Department of Health and Human Services. Summary report on antimicrobials sold or distributed for use in food-producing animals. Silver Spring, MD: FDA; 2014.
24. Stockwell VO, Duffy B. Use of antibiotics in plant agriculture. Rev Sci Tech. 2012; 31(1): 199-210.
25. Bouki C, Venieri D, Diamadopoulos E. Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: a review. Ecotoxicol Environ Saf. 2013; 91: 1-9.
26. Novo A, Andre S, Viana P, Nunes OC, Manaia CM. Antibiotic resistance, antimicrobial residues and bacterial community composition in urban wastewater. Water Res. 2013; 47(5): 1875-87.
27. Kaye KS, Engemann JJ, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 2004; 18(3): 467-511, viii.
28. Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Infect Dis Clin North Am. 2009; 23(4): 817-45.
29. Kalra L, Camacho F, Whitener CJ, Du P, Miller M, Zalonis C, et al Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control. 2013; 41(12): 1253-7.
30. Lombardi S, Scutell M, Felice V, Di Campli E, Di Giulio M, Cellini L. Central vascular catheter infections in a Hospital of Central Italy. New Microbiol. 2014; 37(1): 41-50.
31. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009; 7(9): 629-41.
32. Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014; 27(4): 647-64.
33. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2011. Available from: http://www cdc gov/abcs/reports findings/survreports/mrsa11. pdf 2011.
34. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013; 173(21): 1970-8.
35. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2014. Available from: http://ecdc. europa. eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013. pdf.
36. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010; 50(6): 882-89.
37. Malathi V, Revathi K, Devaraj SN. Antimicrobial resistance an interface between animal and human diseases. Indian J Vet Anim Sci Res. 2020; 43(2): 113-4.
38. Oliver SP, Murinda SE, Jayarao BM. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review. Foodborne Pathog Dis. 2011; 8(3): 337-55.
39. Al-Dawodi R, Farraj MA, Essawi T. Antimicrobial resistance in non-typhi Salmonella enterica isolated from humans and poultry in Palestine. J Infect Dev Ctries. 2012; 6(2): 132-6.
40. Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science. 2013; 341(6153): 1514-7.
41. Li Y, Xie X, Xu X, Wang X, Chang H, Wang C, et al. Nonty-phoidal salmonella infection in children with acute gastroenteritis: prevalence, serotypes, and antimicrobial resistance in Shanghai, China. Foodborne Pathog Dis. 2014; 11(3): 200-6.
42. Najafi M, Lemon SM, Knobler SL, Burroughs T. The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment-workshop summary. Washington, DC: National Academies Press; 2003.
43. Tamang MD, Nam HM, Kim TS, Jang GC, Jung SC, Lim SK. Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea. J Clin Microbiol. 2011; 49(7): 2671-5.
44. Aarestrup FM, Wiuff C, Molbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Anti-microb Agents Chemother. 2003; 47(2): 827-9.
45. Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections. Expert Rev Anti Infect Ther. 2013; 11(10): 1053-63.
46. Li D, Chen Y, Zhang W, Zheng S, Zhang Q, Bai C, et al. Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients. Ir J Med Sci. 2013; 182: 1-7.
47. Webster DP, Young BC, Morton R, Collyer D, Batchelor B, Turton JF, et al. Impact of a clonal outbreak of extended-spec-trum beta-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK. J Antimicrob Chemother. 2011; 66(9): 2126-35.
48. Delgado-Valverde M, Sojo-Dorado J, Pascual A, Rodriguez-Bano J. Clinical management of infections caused by multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis. 2013; 1(2): 49-69.
49. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, Novemberto April 2014. Euro Surveill. 2013; 19(42): 20939.
50. Matteelli A, Roggi A, Carvalho AC. Extensively drug-resistant tuberculosis: epidemiology and management. Clin Epidemiol. 2014; 6: 111.
51. World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance. Geneva: World Health Organization; 2013.
52. World Health Organization (WHO). Indicators of diagnosis, notification and treatment of multidrug-resistant TB, by region or country and year. Available from: https://extranet. who. int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EX T/MDRTB_Indicators_charts (accessed 2 February 2015).
53. World Health Organization (WHO). Population, death rates, and reproductive rates. Available from: http://www. who. int/c hoice/demography/pop_death_rates/en/.
54. Chang K, Yew W. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Respirology. 2013; 18(1): 8-21.
55. WHO Regional Office for Europe. Central Asian and Eastern European Surveillance on Antimicrobial Resistance (CAESAR). Available from: http://www. euro. who. int/en/hea lth-topics/disease-prevention/antimicrobial-resistance/antimicro bial-resistance/central-asian-and-eastern-european-surveillance-on-antimicrobial-resistance-caesar (accessed 11 February 2015).
56. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D. Ready for a world without antibiotics? The pensieres antibiotic resistance call to action. Antimicrob Resist Infect Control. 2012; 1(1): 1-13.
57. Flanagan M, Ramanujam R, Sutherland J, Vaughn T, Diekema D, Doebbeling BN. Development and validation of measures to assess prevention and control of AMR in hospitals. Med Care. 2007; 45(6): 537-44.
58. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005; 18(4): 638-56.
59. Rawlins M, McKenzie D, Mar CD. Antimicrobial stewardship: what's it all about? Aust Presc. 2020; 36(4): 116-3.
60. ECDC (European Centre for Disease Prevention and Control), EFSA (European Food Safety Authority) and EMA (European Medicines Agency). ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals. EFSA J. 2015; 13(1): 4006-4114, [Stockholm/Parma/London: ECDC/EFSA/EMA, 2015].
61. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, et al. Reduction in high rates of antibiotic-non-susceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004; 39(5): 641-48.
62. Kaplan SL, Mason EO, Wald ER, Schutze GE, Bradley JS, Tan TQ, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004; 113(3): 443-49.
63. Howard SJ, Catchpole M, Watson J, Davies SC. Antibiotic resistance: global response needed. Lancet Infect Dis. 2013; 13(12): 1001-03.
64. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015; 517(7535): 455-9.